Moderna (MRNA) shares experienced mostly sideways trading over the past week before seeing renewed upward movement today.
The primary view for the stock is that it is likely to see further declines in the near term.
Following a low that remained well above the support level at $22.32, a recovery is expected to unfold, which could push the stock toward and above the resistance level at $85.60.
If the stock falls below the $22.32 support in the near future, a lower low is expected before any anticipated upward move resumes.
